VIVEK SUBBIAH to Receptors, Cytoplasmic and Nuclear
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Receptors, Cytoplasmic and Nuclear.
Connection Strength
0.303
-
Exportin(g) precision oncology beyond genomics with XPO1 inhibition. Med. 2022 11 11; 3(11):730-732.
Score: 0.160
-
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study. Invest New Drugs. 2021 10; 39(5):1357-1365.
Score: 0.143